Research view
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.
EU-13 is a filter, not a ranking: it only narrows the list.
The University of Texas MD Anderson Cancer Center · Houston, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Cancer Genet, Jan 2026Persistent monosomy 7 in Philadelphia chromosome-negative cells without disease progression over nearly two decades of follow-up in chronic myeloid leukemia.
Toronto, Canada
Singapore, Singapore
New York, United States
Paris, France
Duarte, United States
Los Angeles, United States
Seoul, South Korea
Pierre-Bénite, France
Evanston, United States
10 of 10+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.
Withdrawn
“PI request”Registry text, quoted unchanged. SourceTerminated
A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS
“Change in corporate strategy”Registry text, quoted unchanged. SourceTrials whose registry record says individual participant data (IPD) will be shared.
No trial in this view states that it shares participant data.
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed. Machine-matched links are labelled.